PD40: Prostate Cancer: Localized: Surgical Therapy I

5/5/2019

7:00 AM - 9:00 AM

Location: MCP: W185a

Abstract Presenter(s)

Kenan Celtik, MD

Houston Methodist Hospital

Slides
Stephen Freedland, MD

Cedars-Sinai Medical Center
NG

Natasha Gupta
UH

Ulrike Heberling
Annika Herlemann, MD
JK

Jung Kwon Kim
SK

Sophie Knipper, MD

Slides
Shintaro Narita, MD, PhD

Akita Univerisisty School of Medicine
Aydin Pooli, MD

Urologic Oncology Fellow/Clinical Instructor
Department of Urology, David Geffen School of Medicine at UCLA
NS

Nabeel Shakir
SS

Silvan Sigg

Slides

Presentations:

7:00 AM - 7:10 AM
18-Year Prostate Cancer-Specific Mortality after Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer
Annika Herlemann, MD – Urologische Klinik
7:10 AM - 7:20 AM
Oncologic outcomes after radical prostatectomy for high risk prostate cancer: Impact of various definitions on cancer-specific and overall mortality
Sophie Knipper, MD
7:20 AM - 7:30 AM
Effect of personalized extracorporeal biofeedback device for pelvic floor muscle training on urinary incontinence after robot-assisted radical prostatectomy: A randomized controlled trial
Jung Kwon Kim
7:30 AM - 7:40 AM
A GENOMIC CLASSIFIER SHOWS IMPROVED PREDICTION OF ONCOLOGIC OUTCOMES IN AFRICAN-AMERICAN MEN TREATED WITH RADICAL PROSTATECTOMY
Stephen J. Freedland, MD
7:40 AM - 7:50 AM
Lymph node yield and metastatic pattern after extended pelvic lymph node dissection in robotic-assisted laparoscopic prostatectomy: 14 years of experience
Silvan Sigg
7:50 AM - 8:00 AM
A comparative study of robot-assisted laparoscopic and open retropubic radical prostatectomy in 10,790 men treated by highly trained surgeons for both procedures – the Martini-Klinik experience
Sophie Knipper, MD
8:00 AM - 8:10 AM
Validation of an easily applicable questionnaire-suited comorbidity index in 5050 consecutive patients undergoing radical prostatectomy
Ulrike Heberling
8:10 AM - 8:20 AM
Impact of positive surgical margin and nerve-sparing status on biochemical recurrence in patients with prostate cancer treated with radical prostatectomy: a multicenter retrospective study
Shintaro Narita, MD, PhD
8:20 AM - 8:30 AM
Evaluating the Impact of Length of Time from Diagnosis to Surgery in Patients with Unfavorable Intermediate to Very High-Risk Clinically Localized Prostate Cancer
Natasha Gupta
8:30 AM - 8:40 AM
Mortality Following Radical Prostatectomy (RP) or Intensity Modulated Radiation Therapy (IMRT) for Localized Prostate Cancer (PCa) – An Analysis of the CDC Prostate Cancer Data Quality and Patterns of Care Study (CDC POC-BP)
Kenan E. Celtik, MD
8:40 AM - 8:50 AM
The role of 68Ga-PSMA PET-CT in initial staging of treatment-naïve high risk prostate cancer.
Aydin Pooli, MD – UCLA Health
8:50 AM - 9:00 AM
IMPACT OF SINGLE DOSE PERIOPERATIVE ENOXAPARIN ON RATE OF THROMBOEMBOLIC EVENTS FOLLOWING ROBOTIC ASSISTED PROSTATECTOMY: A HOSPITAL SYSTEM-WIDE ANALYSIS
Nabeel Shakir